DIO디오

DIO's trailing profits have recovered to positive territory after a loss-making 2024, but the shares are down sharply over the past year.

DIO, a Korean maker of dental implants, reported trailing-twelve-month revenue of ₩174B and net income of ₩22B to H1 2026, with a return to profit after losses in 2024 and 2025. The share price of ₩10,080 sits well below its 52-week high of ₩19,400, and the data shows a one-year return of -41.4%. Leverage is moderate, with borrowings of ₩76B against cash of ₩38B.

What stands out

• Trailing operating margin is 8.1% and net margin 12.7%, though net income is helped by items beyond core operations that the data does not break down.
• Full-year 2025 showed revenue growth of 37.1% to ₩164B but a net loss of ₩1.4B, so the recovery is recent and not yet consistent across years.
• Valuation metrics in the data are low versus the listed peers: P/E of 6.1 and P/B of 0.7, while peers range from 13.2 to 71.9 on P/E.
• The fair value model in the data gives a base value of ₩8,330, a bear of ₩2,429 and a bull of ₩19,628; these are model outputs, not forecasts.
• Foreign ownership fell from 15.1% to 13.4% over the last 60 days, and foreign investors were net sellers over the last 20 days.

What to watch

• Upcoming results and any updates to the trailing profit figures, since 2025 and 2024 were loss-making years.
• The share buyback decision filed on 2026-10-19, including how much is planned and whether it is carried out.
• Progress on the shareholders' meeting matters and the trust contract termination reported in September; the data does not explain their impact.